Indefinite Delivery Contract SPE2DX19D9540

The Defense Logistics Agency (DLA) awarded an Indefinite Delivery Contract (IDC) with a maximum potential value of $4,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which runs through December 31, 2025, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide.

Through this IDC and associated delivery orders, DMS Pharmaceutical Group provides the Department of Defense (DoD) and Department of Veterans Affairs (VA) with a diverse array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract does not have any set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. The delivered items include common medications as well as specialized pharmaceuticals such as Xolair, Trikafta, Keytruda, Botox, and Nucala, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.